Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Analisi di costo-efficacia di rituximab più CHOP versus ProMACE-CytaBOM nel trattamento del linfoma diffuso a grandi cellule B: l’esperienza di Reggio Emilia, Giornale Italiano di Health Technology Assessment, June 2009, Springer Science + Business Media,
DOI: 10.1007/bf03320719.
You can read the full text:

Read

Contributors

The following have contributed to this page